Toggle light / dark theme

The genomes of the long dead are turning up all sorts of unexpected and controversial findings.

Geneticist David Reich used to study the living, but now he studies the dead.

The precipitating event came in the form of 40,000-year-old Neanderthal bones found in a Croatian cave. So well-preserved were the bones that they yielded enough DNA for sequencing, and it became Reich’s job in 2007 to analyze the DNA for signs that Neanderthals interbred with humans—a idea he was “deeply suspicious” of at the time.

Read more

An article I wrote:


Study based upon human skeletal muscle aging, mutagenesis, and the role of #satellite cells

“A more comprehensive understanding of the interplay of stem cell–intrinsic and extrinsic factors will set the stage for improving cell therapies capable of restoring tissue homeostasis and enhancing muscle repair in the aged.

Human aging has multiple effects on the human body. One of the effects of human aging is the reduction in skeletal muscle (SkM) function and a reduction in the number and activity of satellite cells (SCs), the resident stem cells. The whole genome of single SC clones of the leg muscle vastus lateralis from healthy individuals of different ages (21–78 years) was analyzed, to study the specific connection between SC aging and muscle impairment. In healthy adult muscle rapid increase of SCs is consistent with the accumulation rate of 13 somatic mutations per genome per year. Mutations typically do not happen in SkM-expressed genes because they are protected. However, as mutations in exons and promoters increase, genes involved in SC activity and muscle function are targeted which results in aging. Exons are coding sections of an RNA transcript, or the DNA encoding it, that are translated into protein. Proteins are the synthesis of molecules.

Read more

I ntelligence could be measured with a swab of saliva, or drop of blood, after scientists showed for the first time that a person’s IQ can be predicted just by studying their DNA.

In the largest ever study looking at the genetic basis for intelligence, researchers at the University of Edinburgh and Harvard University discovered hundreds of new genes linked to brain power.

Previous studies have suggested that between 50 per cent and 75 per cent of intelligence is inherited, and the rest comes through upbringing, friendship groups and education. That figure was calculated by studying identical twins who share the same DNA, therefore any differences in IQ between them must be non-genetic.

Read more

MhAX, or Microhomology-Assisted eXcision.


Gene editing has the power to completely reshape our world.

It promises everything from fixing the genetic faults that lead to disease, to destroying disease-causing microbes, to improving the nutrition of the foods we eat and even resurrecting extinct species like the wooly mammoth — all largely thanks to the genetic editing tool CRISPR, which has both popularized this work and made it possible.

Now, researchers in Japan have developed a new gene editing technique that uses CRISPR alongside a DNA repair system to modify a single DNA base in the human genome, with what the team’s press release calls “absolute precision.”

Read more

http://www.blogtalkradio.com/dr-jeanette-gallagher/2018/03/09/can-we-help-our-body-regenerate-in-a-changing-world-of-transformation

Some cancer cells express some of the same genes that senescent cells do, so it makes sense that drugs that destroy senescent cells may also destroy cancer cells. This was what the researchers in this new study set out to test.

However, in this experiment, the researchers discovered that the chosen senolytic drugs were not effective at destroying cancer cells with senescence-associated gene expression. While cancer cells and senescent cells do share some common properties, they are also quite different at an epigenetic level.

The researchers did, however, demonstrate that a so-called “suicide gene therapy” that causes both senescent cells and cancer cells to kill themselves worked by targeting senescence-associated p16Ink4a. This approach is similar to that of SENS spin-off company Oisin Biotechnologies, which is using a suicide gene therapy to eliminate senescent cells.

Read more